Effective heart failure management at scale: What leaders need to know
This webinar is on-demand and can be viewed at your convenience.
Heart failure with preserved ejection fraction and heart failure with mildly reduced ejection fraction are increasingly prevalent and complex syndromes within the broader spectrum of heart failure. As understanding of these conditions continues to evolve, so does the need for a consistent, evidence-based approach to diagnosis, classification and management.
This webinar features perspectives from clinical leaders at SSM Health and the University of Glasgow to explore the foundations of HFpEF and HFmrEF. They'll review how these syndromes are defined and diagnosed in practice, with attention to epidemiology, pathophysiology and patient phenotypes.
The discussion also examines the clinical significance of HFpEF and HFmrEF, including risks of hospitalization and mortality, and reviews current evidence-based therapies and treatment considerations.
Insights include:
Epidemiology and pathophysiology of HFpEF and HFmrEF
Definitions and diagnostic considerations in clinical practice
Key HFpEF and HFmrEF patient phenotypes
Clinical significance and current evidence-based therapies
Presenters:
Georges Chahoud, MD, FACC, FAHA, FHFSA, FASE
Regional Director, Heart Failure Clinical Program-SSM Health, St. Louis & Southern IL
Pardeep Jhund, MD, FESC, FHFA
Professor, Cardiology & Epidemiology, University of Glasgow
